SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #860CAS 1区Top JournalHybrid

European Journal of Cancer

Abbreviation (ISO):EUR. J. CANCER
Country: England•WoS SCIE Quartile: Q1•Scopus SJR: 2.692•SCImago Rank: #860•Identifier (ISSN):0959-8049(Print)/1879-0852(Online)•Articles / Year: 436•Estimated Publication Fee (APC): $4,006 USD
Clarivate IF (2026)Q1
7.9
↑ +0.8

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
193

193 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate2.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
436articles/year
43.23% Gold OA•86.95% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 7.9)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 7.9)
🔵 Computed
20253.00đ
WoS Q1 có IF ≥ 5.0(IF: 7.1)
🔵 Computed
20243.00đ
WoS Q1 có IF ≥ 5.0(IF: 7.6)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.4)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 10.002)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 9.162)
🔵 Computed
20203.00đ
WoS Q1 có IF ≥ 5.0(IF: 7.275)
🔵 Computed
20193.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.68)
🔵 Computed
20183.00đ
WoS Q1 có IF ≥ 5.0(IF: 7.191)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

The European Journal of Cancer (including EJC Supplements), is an international comprehensive oncology journal that publishes original research, editorial comments, review articles and news on experimental oncology, clinical oncology (medical, paediatric, radiation, surgical), translational oncology, and on cancer epidemiology and prevention. The Journal now has online submission for authors.

Topics Covered (Recognized by AI)
Medicine96.7%Biology89.1%Internal medicine85%Genetics82.5%Cancer60.9%Oncology49.2%Pathology43.5%Chemistry42.2%Surgery41.3%Biochemistry34.1%Cancer research29.1%Chemotherapy22.2%Breast cancer21.9%Immunology21.7%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #860Scopus Q1SCImago Profile
Scopus Coverage:1990-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
2.692

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
263

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
6.50

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,006 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations8,409
3-Year Documents1,591
Citable Documents1,381

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)4

Citations in government and international policy documents

Female Author Rate45.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
OncologyQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
5.3周
Average time to first editorial decision
Online Publication Speed
7.3周
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Elsevier Ltd
Publication Language
English
Frequency
Semimonthly
Founding Year
1990
Editorial Address
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
45/333Q1
ONCOLOGY
JCISCIE
39/333Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—645154
20257.17002,380
20247.61,3615,288
20238.45017,692
202210.0021,22313,726
20219.16270319,926
20207.27598520,873
20196.6855720,524
20187.1911,01220,342
2017—1,07529,403
2016—1,68230,961
2015—2,48927,155
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for European Journal of Cancer

WoS Q1
47912201820192020202120222023202420257.10
Annual Impact Factor Metric
2025:7.1

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 93fb8d59-1273-4e86-b46d-4d94d45c1281
Database Updated: 2026-10-01